24/02/2021
π Retinoic acid receptor alpha (RAR-Ξ±) is a nuclear hormone receptor that binds to a DNA sequence, normally as a heterodimer with retinoid X receptor (RXR).
π Its ligands? All-trans retinoic acid or ATRA and 9-cis retinoic acid
π Without ligands -> RAR-RXR heterodimer INHIBITS transcription by recruiting transcription corepressors
π In the presence of ligand -> the co-repressor complexes dissociate from RAR-RXR, and transcriptional activation is induced.
π As its name suggests, a corepressor is a molecule (a large protein) that down-regulates the expression of certain genes, while a coactivator can enhance gene expression.
π Acute promyelocytic leukemia (APL) is an aggressive type of acute myeloid leukemia in which there are too many immature blood-forming cells (promyelocytes) in the blood and bone marrow.
π APL is mostly caused by a chromosomal translocation t(15;17) between the retinoic acid receptor alpha gene (RARΞ±) and promyelocytic leukemia gene (PML).
π This way, a new, hybrid protein is formed: PML-RARΞ±.
π PML-RARΞ± ENHANCES the binding of transcriptional corepressors and prevents cellular differentiation from occurring, under PHYSIOLOGIC levels of ATRA
π PHARMACOLOGICAL concentrations of ATRA can dissociate the corepressors from RARΞ± and allow DNA transcription and DIFFERENTIATION of the promyelocytes into mature GRANULOCYTES.
π Unlike other chemotherapies, ATRA does not directly kill the malignant cells.
π ATRA induces the terminal differentiation of the leukemic promyelocytes, after which these differentiated malignant cells undergo spontaneous apoptosis on their own.